Literature DB >> 9162044

Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the m2 muscarinic acetylcholine receptor.

R Pals-Rylaarsdam1, M M Hosey.   

Abstract

Short term exposure of m2 muscarinic acetylcholine receptors (m2 mAChRs) to agonist causes a rapid phosphorylation of the activated receptors, followed by a profound loss in the ability of the m2 mAChR to activate its signaling pathways. We have used site-directed mutagenesis to identify two clusters of Ser/Thr residues in the third intracellular loop of the m2 mAChR that can serve as redundant targets for agonist-dependent phosphorylation. Mutation of both clusters of Ser/Thr residues to alanines abolished agonist-dependent phosphorylation, while wild-type levels of m2 mAChR phosphorylation were observed in mutant receptors with only one or the other cluster mutated. However, the functional effects of phosphorylation of these two "redundant" clusters were not equivalent. No receptor desensitization was observed in an m2 mAChR with residues Thr307-Ser311 mutated to alanine residues. In contrast, mutation of the other Ser/Thr cluster, residues Ser286-Ser290, to alanines produced a receptor that continued to desensitize. Internalization of the m2 mAChR was promoted by phosphorylation of either cluster, suggesting that distinct mechanisms with unique structural requirements act downstream of m2 mAChR phosphorylation to mediate receptor desensitization and receptor internalization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9162044     DOI: 10.1074/jbc.272.22.14152

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 2.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

3.  Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.

Authors:  Luis E Gimenez; Seunghyi Kook; Sergey A Vishnivetskiy; M Rafiuddin Ahmed; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 4.  G-protein-coupled receptor phosphorylation: where, when and by whom.

Authors:  A B Tobin
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

Review 5.  Endocytic regulation of alkali metal transport proteins in mammals, yeast and plants.

Authors:  José Miguel Mulet; Vicent Llopis-Torregrosa; Cecilia Primo; Ma Carmen Marqués; Lynne Yenush
Journal:  Curr Genet       Date:  2013-08-23       Impact factor: 3.886

6.  Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor.

Authors:  Yinglong Miao; Alisha D Caliman; J Andrew McCammon
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

Review 7.  The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors.

Authors:  Jeffrey S Smith; Sudarshan Rajagopal
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

Review 8.  The structural basis of the arrestin binding to GPCRs.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Mol Cell Endocrinol       Date:  2019-01-28       Impact factor: 4.102

9.  RACK1 associates with muscarinic receptors and regulates M(2) receptor trafficking.

Authors:  Cindy L Reiner; Jennifer S McCullar; Rebecca L Kow; Joshua H Le; David R Goodlett; Neil M Nathanson
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

Review 10.  Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling.

Authors:  Andrew B Tobin; Adrian J Butcher; Kok Choi Kong
Journal:  Trends Pharmacol Sci       Date:  2008-07-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.